NEW DELHI: A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their vaccine candidates Covid-19, official sources said Monday. night.
The decision was made late Monday night after Hyderabad-based Bharat Biotech became the third pharmaceutical company to apply to the Comptroller General of Medicines of India (DCGI) for an emergency use authorization for its Covid-19 vaccine developed in the country, Covaxin.
On December 4, the Indian arm of US pharmaceutical giant Pfizer applied for approval of its vaccine to the central drug regulator, after the firm obtained such authorization in the UK and Bahrain.
The Pune-based Serum Institute of India sought a go-ahead for the Oxford Covid-19 vaccine, Covishield, on December 6.
“DCGI has already started processing applications. The Covid-19 Expert Committee at CDSCO will deliberate on applications from Pfizer, Serum Institute of India, and Bharat Biotech seeking emergency use authorization for their Covid- vaccines. 19 on December 9, “a source said.
At an all-party meeting held on December 4, Prime Minister Narendra Modi had expressed hope that a Covid-19 vaccine could be ready in a few weeks.
The decision was made late Monday night after Hyderabad-based Bharat Biotech became the third pharmaceutical company to apply to the Comptroller General of Medicines of India (DCGI) for an emergency use authorization for its Covid-19 vaccine developed in the country, Covaxin.
On December 4, the Indian arm of US pharmaceutical giant Pfizer applied for approval of its vaccine to the central drug regulator, after the firm obtained such authorization in the UK and Bahrain.
The Pune-based Serum Institute of India sought a go-ahead for the Oxford Covid-19 vaccine, Covishield, on December 6.
“DCGI has already started processing applications. The Covid-19 Expert Committee at CDSCO will deliberate on applications from Pfizer, Serum Institute of India, and Bharat Biotech seeking emergency use authorization for their Covid- vaccines. 19 on December 9, “a source said.
At an all-party meeting held on December 4, Prime Minister Narendra Modi had expressed hope that a Covid-19 vaccine could be ready in a few weeks.
.
